SlideShare uma empresa Scribd logo
1 de 6
Baixar para ler offline
GUIDELINES FOR PRINCIPALS ON PLANNING AND
EVALUATIONS OF TRAININGS

17.04.2013

1. OBJECTIVE
This document aims to provide guidance on the content and the format of the submissions that will be
done to Turkish Medicine and Medical Device Agency regarding the planned training programs about
good clinical practices and clinical research.

2.

BASIC PRINCIPLES
2.1 The participants’ number should be minimum 40 and maximum 80.
2.2 There should be at least 2 workshops according to training composition.
2.3 There should be at least one role-play video if it is appropriate for planned training
composition.
2.4 There should be a laptop with the internet connection, projector, DVD or VCD player, audio
system (including lapel microphone) at the training place.
2.5 There should be “question and answer application” supported by a computer system.
2.6 The physical place for training should be a big lounge with the table sitting arrangement and
preferred to be changed as 2 small lounges if needed.
2.7 The Training Coordinator who will be qualified to answer all kind of management and
educational questions should be assigned during the training.

3. APPLICATIONS
3.1 A Quality Assurance Responsible should be present during the training for assessing
presentation of the trainer, trainers’ ability to answers questions raised and trainers’ interest
in participants.
3.2 The expectation of participants should be questioned at the beginning of the training and
compared with the anticipated objectives.
3.3 The participants should be pre-tested to evaluate their knowledge level at the beginning of the
training
3.4 Mandatory training attendances should be planned as ¾ attendance per course
3.5 Preferably the signature of participants should be collected for each presentation, if not
possible for each session.
3.6 Each participant should be provided with a name tag, agenda of training, course notes and
also note book and a pen.
3.7 If the training is planned for more than one day, the training from previous day should be
summarized.
3.8 Before starting the advanced training session, participants should be reminded about the
content of the basic training.
3.9 Training presentations and workshops should not exceed respectively 40 minutes, and 3
hours.
4. EVALUATIONS
4.1 Training evaluation should be completed under2 titles; “the participants’ success assessment”
and “evaluation of the training program”
GUIDELINES FOR PRINCIPALS ON PLANNING AND
EVALUATIONS OF TRAININGS

17.04.2013

The participants’ success assessment; the participants’ success should be evaluated
with an exam at the end of the training. Participants who have passed the exam and
whose continuation is appropriate should receive a “Certificate of Achievement”
.Participants who have failed the exam should be given a “Registration Certificate”.
4.1.2 Evaluation of the training program; In order to evaluate effectiveness of the training
program, feedbacks of the participants should be collected.
4.2 “Certificate of Achievement” and/or “Registration Certificate” should be signed by Training
Coordinator.
4.1.1

5. TRAINERS
5.1 Trainers should experts on their subjects.
5.2 Trainers who are not academics should receive the “Train the Trainer” training.
6. EXAMPLES FOR THE TRAINING PROGRAM
Below listed training programs are suggested as example. The content of the course can be
amended according to course title.
6.1 Ethical approach and considerations in clinical trials
6.1.1 Duration of the Training: It should be minimum 2, maximum 4 days
6.1.2 Target Audience: The training should be intended for Ethics Committee members and
investigators.
6.1.3 Objective: The objective of the training is to understand basic ethical approaches and
principles in clinical research.
6.1.4 It may planned as 2 modules;
The scope of Module 1: The scope of the training may include following topics;
 Philosophy and historical progress of ethics in clinical research
 Ethical aspects of clinical research
 National legislations in clinical research
 Mission, authority and responsibilities of Ethics Committees
 Qualification of Ethics Committees
 Composition, functions and operations of Ethics Committees
 Items that make clinical research ethical
 Wrong attitudes in clinical research
 Conflict of interest in clinical research
 Statistical evaluation in clinical research and reliability of data
 Ethical approval process
 Ethics Committee/ investigator relationship
The scope of Module 2: The scope of the training may include following topics;
 Quality control and assurance in clinical research
 Methodology in clinical trials
 Statistical approaches in clinical trials
 Clinical trials in Geriatric population
 Source of mistakes in different types of clinical research
GUIDELINES FOR PRINCIPALS ON PLANNING AND
EVALUATIONS OF TRAININGS

17.04.2013

 Ethical aspects of observational studies
 Problems in implementation
 Use of placebo in psychiatric studies
 Ethical aspects of genetic researches
 Ethical approaches in clinical trials involving female subjects
 Clinical trials involving healthy subjects
 Pharmacovigilence and adverse events
 Clinical trials in pediatric population
6.2 Training program about the standardization requirements for structuring of Ethics
Committees
6.2.1 Duration of the Training: It should be minimum 2, maximum 4 days
6.2.2 Target Audience: The training should be intended for Ethics Committee members.
6.2.3 Objective: The objective of the training is to understand basic ethical approaches and
principles in clinical research.
6.2.4 Scope; The scope of the training may include following topics;
 European Union Directives, national legislations
 Legal regulations in clinical trials
 What is Good Clinical Practice(GCP)?
 Composition, functions and operations of Ethics Committees
 Qualification of Ethics Committees
 Mission, authority and responsibilities of Ethics Committees
 What is ethics? Bioethics and ethics in clinical research
 Historical progress of ethical values in clinical research
 Patient rights
 Importance of Declaration of Helsinki and its parts to follow
 Importance of Informed Consent Form (ICF) and evaluation of ICD during
submissions(workshop)
 The need for drug development, milestones in drug development and
different phases of clinical trials
 Statistical evaluation in clinical research and reliability of data
 Quality Management-basic principles
 Definition of “Standard Operating Procedure”, its reason for use and content
 Preparation of “Standard Operating Procedure”(workshop)
 Quality control and assurance in clinical research
 Budgeting in clinical trials: payments to subjects and investigators
 Evaluation of a submission folder (workshop)
 Ethic approval process
 Safety notifications in clinical research
 Ethics Committee/ investigator relationship
 Ethics Committee/ sponsor relationship
 Conflict of interest in clinical research
6.3 Clinical Research/Basic Training Program
GUIDELINES FOR PRINCIPALS ON PLANNING AND
EVALUATIONS OF TRAININGS
6.3.1
6.3.2
6.3.3
6.3.4

17.04.2013

Duration of the Training: It should be minimum 2, maximum 4 days
Target Audience: The training should be intended for investigators and sponsors.
Objective: The objective of the training is to understand basic principles of clinical
research.
:It may planned as 2 modules;
The scope of Module 1: The scope of the training may include following topics;
 New Drug development process
 Clinical research terminology
 The duties and responsibilities of the parties involved in Clinical Trials
 Observational studies
 Non-Drug clinical trials terminology
 Information of subjects and informed consent form
 Legal regulations
 Adverse event reporting
 The practices of local authority in accordance with the relevant legislation
The scope of Module 2: The scope of the training may include following topics;
 Clinical Trial Protocol
 Investigators’ Brochure
 Basic Statistical Terms
 Pharmacokinetic Terms
 Pharmacogenetic and Pharmacogenomic Terms
 Quality Control in Clinical Trials
 Protection of patients and Helsinki Declarations
 Designing of Clinical Trials
 Methodology in Clinical Trials (blinding, randomization etc.)
 Placebo Controls in Clinical Trials
 Project Management in Clinical Trials
 Special parameters in clinical trials(Life Quality etc. )
 Data Management(collection of the data, data entry, validation of the data
etc)
 Data reliability/safety

6.4 Monitoring in Clinical Trials
6.4.1 Duration of the Training: It should be minimum 2, maximum 3 days
6.4.2 Target Audience: The training should be intended for sponsors and monitors.
6.4.3 Objective: The objective of the training is to understand basic principles of
monitoring in clinical trials.
6.4.4 Scope; The scope of the training may include following topics;
 Monitoring policy
 Legal regulations in clinical trials
 Introduction to Good Clinical Practice(GCP)
 Introduction to Good Laboratory Practice(GLP)
 Quality assurance and standard operating procedures
GUIDELINES FOR PRINCIPALS ON PLANNING AND
EVALUATIONS OF TRAININGS

17.04.2013









Terminology in clinical trials
Essential documents in study files
Inappropriate behavior in clinical trials
Selection and qualifications of Monitors
Monitor’s responsibilities
Reporting
Data Management(collection of the data, data entry, validation of the data
etc)
 Data reliability/safety
 Investigational product accountability and destruction
6.5 Clinical Research Nursing Training Program
6.5.1 Duration of the Training: It should be minimum 2, maximum 3 days
6.5.2 Target Audience: The training should be intended for clinical research nurses
6.5.3 Objective: The objective of the training is to understand basic principles of clinical
trials.
6.5.4 Scope; The scope of the training may include following topics;
 Clinical research terminology
 Legal regulations in clinical trials
 Definition of clinical research and steps of designing clinical trials
 Ethics Committees in clinical trials
 Management of trial site
 Clinical research nursing
 Responsibilities in clinical researches
 Randomization procedures and blinding in clinical trials
 Source documents in clinical trials
 Submission periods in clinical trials
 Investigational product procedures
 Study close-out
 Adverse event reporting
6.6 Advanced Clinical Research Training Program
6.6.1 Duration of the Training: It should be minimum 2, maximum 4 days
6.6.2 Target Audience: The training should be intended for investigators and sponsors.
6.6.3 Objective: The objective of the training is to understand more specific topics of
clinical research.
6.6.4 Scope; The scope of the training may include following topics;
 Data management in Clinical Trials
 Risk Management in Clinical Trials
 Finding volunteers and retention in Clinical Trials
 Types of research on specific topics such as oncology trials, psychiatry trials
 Evaluation of statistical data
 Translational researches
GUIDELINES FOR PRINCIPALS ON PLANNING AND
EVALUATIONS OF TRAININGS

17.04.2013

 Pharmacogenetic and Pharmacogenomic
 Causality relationships in safety notifications
 The scales used in research and evaluations
Protocol Writing
6.7 Clinical Research Pharmacist Training Program
6.7.1 Duration of the Training: It should be minimum 2, maximum 3 days
6.7.2 Target Audience: The training should be intended for clinical research pharmacists
6.7.3 Objective: The objective of the training is to understand basic principles of clinical
trials.
6.7.4 Scope; The scope of the training may include following topics;
 Clinical research terminology
 Legal regulations in clinical trials
 Definition of clinical research and steps of designing clinical trials
 Management of trial site
 Task and responsibilities of clinical research pharmacists
 Randomization procedures and blinding in clinical trials
 Source documents in clinical trials
 Investigational product procedures and accountability
 Study close-out
 Adverse event reporting

7. SUBMISSION AND APPROVAL
7.1 Submissions to Turkish Medicine and Medical Device Agency should be completed latest one
month before with the form and cover letter published in Institution’s website. The approval
for organization of the training is granted upon evaluation, to those who were found qualified.
7.2 The training should be organized in collaboration with an institution, an university or a
research and training hospital.
8. ANNULLED REGULATIONS
Guidance for Principals on Planning and Evaluations of Trainings which entered into force in
accordance with the presidency approval dated 28.05.2012 and no 48797 was abolished.
9. ENFORCEMENT
This guideline will enter into force on the date of approval.

Mais conteúdo relacionado

Mais procurados

Patients satisfaction on clinical laboratory services at nekemte
Patients satisfaction on clinical laboratory services at nekemtePatients satisfaction on clinical laboratory services at nekemte
Patients satisfaction on clinical laboratory services at nekemteAlexander Decker
 
Student pt evaluationform
Student pt evaluationformStudent pt evaluationform
Student pt evaluationformBASIT Rehman
 
First steps in improving phlebotomy: the challenge to improve quality, produc...
First steps in improving phlebotomy: the challenge to improve quality, produc...First steps in improving phlebotomy: the challenge to improve quality, produc...
First steps in improving phlebotomy: the challenge to improve quality, produc...NHS Improvement
 
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...Yasser Sami Abdel Dayem Amer
 
LOGBOOK PHARMACOLOGY - 29-03-2021 - GMC DATIA
LOGBOOK PHARMACOLOGY - 29-03-2021 - GMC DATIALOGBOOK PHARMACOLOGY - 29-03-2021 - GMC DATIA
LOGBOOK PHARMACOLOGY - 29-03-2021 - GMC DATIADr SURENDRA BOUDDH
 
Supervision, monitoring and evaluation of research
Supervision, monitoring and evaluation of researchSupervision, monitoring and evaluation of research
Supervision, monitoring and evaluation of researchAshok Pandey
 
Pillars of Quality : An Overview of NABH - Dr. A.M Joglekar at Knowledge Seri...
Pillars of Quality : An Overview of NABH - Dr. A.M Joglekar at Knowledge Seri...Pillars of Quality : An Overview of NABH - Dr. A.M Joglekar at Knowledge Seri...
Pillars of Quality : An Overview of NABH - Dr. A.M Joglekar at Knowledge Seri...Hosmac India Pvt Ltd
 
Clinical Practice Guidelines / Pathways as a Strategy / Tool for Hospital Qua...
Clinical Practice Guidelines / Pathways as a Strategy / Tool for Hospital Qua...Clinical Practice Guidelines / Pathways as a Strategy / Tool for Hospital Qua...
Clinical Practice Guidelines / Pathways as a Strategy / Tool for Hospital Qua...Reynaldo Joson
 
5th ed. NABH Accreditation Standards for Hospitals April 2020
5th ed. NABH Accreditation Standards for Hospitals April 20205th ed. NABH Accreditation Standards for Hospitals April 2020
5th ed. NABH Accreditation Standards for Hospitals April 2020Dr Jitu Lal Meena
 
Tests of Knowledge: How Can They Contribute to Maintenance of Certification ...
Tests of Knowledge: How Can They Contribute to Maintenance of Certification ...Tests of Knowledge: How Can They Contribute to Maintenance of Certification ...
Tests of Knowledge: How Can They Contribute to Maintenance of Certification ...IAMRAreval2015
 

Mais procurados (15)

Patients satisfaction on clinical laboratory services at nekemte
Patients satisfaction on clinical laboratory services at nekemtePatients satisfaction on clinical laboratory services at nekemte
Patients satisfaction on clinical laboratory services at nekemte
 
Setting Standards for Research Methods
Setting Standards for Research Methods Setting Standards for Research Methods
Setting Standards for Research Methods
 
Nabh quality improvement in ed 06.07 17
Nabh quality improvement in ed 06.07 17Nabh quality improvement in ed 06.07 17
Nabh quality improvement in ed 06.07 17
 
Student pt evaluationform
Student pt evaluationformStudent pt evaluationform
Student pt evaluationform
 
First steps in improving phlebotomy: the challenge to improve quality, produc...
First steps in improving phlebotomy: the challenge to improve quality, produc...First steps in improving phlebotomy: the challenge to improve quality, produc...
First steps in improving phlebotomy: the challenge to improve quality, produc...
 
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
Clinical Practice Guidelines implementation & Auditing in the Pediatrics Depa...
 
LOGBOOK PHARMACOLOGY - 29-03-2021 - GMC DATIA
LOGBOOK PHARMACOLOGY - 29-03-2021 - GMC DATIALOGBOOK PHARMACOLOGY - 29-03-2021 - GMC DATIA
LOGBOOK PHARMACOLOGY - 29-03-2021 - GMC DATIA
 
Supervision, monitoring and evaluation of research
Supervision, monitoring and evaluation of researchSupervision, monitoring and evaluation of research
Supervision, monitoring and evaluation of research
 
Pillars of Quality : An Overview of NABH - Dr. A.M Joglekar at Knowledge Seri...
Pillars of Quality : An Overview of NABH - Dr. A.M Joglekar at Knowledge Seri...Pillars of Quality : An Overview of NABH - Dr. A.M Joglekar at Knowledge Seri...
Pillars of Quality : An Overview of NABH - Dr. A.M Joglekar at Knowledge Seri...
 
Assessement tools
Assessement tools  Assessement tools
Assessement tools
 
Clinical Practice Guidelines / Pathways as a Strategy / Tool for Hospital Qua...
Clinical Practice Guidelines / Pathways as a Strategy / Tool for Hospital Qua...Clinical Practice Guidelines / Pathways as a Strategy / Tool for Hospital Qua...
Clinical Practice Guidelines / Pathways as a Strategy / Tool for Hospital Qua...
 
5th ed. NABH Accreditation Standards for Hospitals April 2020
5th ed. NABH Accreditation Standards for Hospitals April 20205th ed. NABH Accreditation Standards for Hospitals April 2020
5th ed. NABH Accreditation Standards for Hospitals April 2020
 
Duplicate yhdue
Duplicate yhdueDuplicate yhdue
Duplicate yhdue
 
Tests of Knowledge: How Can They Contribute to Maintenance of Certification ...
Tests of Knowledge: How Can They Contribute to Maintenance of Certification ...Tests of Knowledge: How Can They Contribute to Maintenance of Certification ...
Tests of Knowledge: How Can They Contribute to Maintenance of Certification ...
 
Nephrology Specialists and Resident’s Perception towards Training Program at ...
Nephrology Specialists and Resident’s Perception towards Training Program at ...Nephrology Specialists and Resident’s Perception towards Training Program at ...
Nephrology Specialists and Resident’s Perception towards Training Program at ...
 

Destaque

Entreprise numerique panorama 2013 cedhys
Entreprise numerique panorama 2013 cedhysEntreprise numerique panorama 2013 cedhys
Entreprise numerique panorama 2013 cedhysSven Awege
 
Clinical data sharing: why publishing negative and less impactful results is ...
Clinical data sharing: why publishing negative and less impactful results is ...Clinical data sharing: why publishing negative and less impactful results is ...
Clinical data sharing: why publishing negative and less impactful results is ...Ann-Marie Roche
 
Patient independence through social media jan 2013 shared
Patient independence through social media jan 2013 sharedPatient independence through social media jan 2013 shared
Patient independence through social media jan 2013 sharedSven Awege
 
Realtime closed loop marketing in the pharmaceutical industry_annual global p...
Realtime closed loop marketing in the pharmaceutical industry_annual global p...Realtime closed loop marketing in the pharmaceutical industry_annual global p...
Realtime closed loop marketing in the pharmaceutical industry_annual global p...Sven Awege
 
Strategies for promoting health
Strategies for promoting healthStrategies for promoting health
Strategies for promoting healthG Masso
 

Destaque (6)

Entreprise numerique panorama 2013 cedhys
Entreprise numerique panorama 2013 cedhysEntreprise numerique panorama 2013 cedhys
Entreprise numerique panorama 2013 cedhys
 
Clinical data sharing: why publishing negative and less impactful results is ...
Clinical data sharing: why publishing negative and less impactful results is ...Clinical data sharing: why publishing negative and less impactful results is ...
Clinical data sharing: why publishing negative and less impactful results is ...
 
Patient independence through social media jan 2013 shared
Patient independence through social media jan 2013 sharedPatient independence through social media jan 2013 shared
Patient independence through social media jan 2013 shared
 
Pharmacovigilence
PharmacovigilencePharmacovigilence
Pharmacovigilence
 
Realtime closed loop marketing in the pharmaceutical industry_annual global p...
Realtime closed loop marketing in the pharmaceutical industry_annual global p...Realtime closed loop marketing in the pharmaceutical industry_annual global p...
Realtime closed loop marketing in the pharmaceutical industry_annual global p...
 
Strategies for promoting health
Strategies for promoting healthStrategies for promoting health
Strategies for promoting health
 

Semelhante a Guidelines for principals on planning and evaluations of trainings,Guidelines for observational studies conducted on drugs, published by Turkish Medicine and Medical Device Agency

Ich gcp guidlines 2021
Ich gcp guidlines 2021Ich gcp guidlines 2021
Ich gcp guidlines 2021KhalandarMulla
 
Introduction to clinical research
Introduction to clinical researchIntroduction to clinical research
Introduction to clinical researchAnor Abidin
 
Cinical trial protocol writing
Cinical trial protocol writingCinical trial protocol writing
Cinical trial protocol writingUrmila Aswar
 
Simple steps to NABH Accreditation
Simple steps to NABH AccreditationSimple steps to NABH Accreditation
Simple steps to NABH AccreditationLallu Joseph
 
Lab qms lesson one
Lab qms  lesson oneLab qms  lesson one
Lab qms lesson oneZeinabOmar7
 
Clinical Trial Program
Clinical Trial ProgramClinical Trial Program
Clinical Trial ProgramAADYA
 
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIALICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIALMOHAMMED FAHEEM KHAN
 
mohammad CV June 2014 (2)
mohammad CV June 2014 (2)mohammad CV June 2014 (2)
mohammad CV June 2014 (2)Mohammad Salim
 
Health screener diploma national update 2019 figures and support
Health screener diploma national update 2019 figures and supportHealth screener diploma national update 2019 figures and support
Health screener diploma national update 2019 figures and supportPHEScreening
 
Psychology Education And Training In The United States
Psychology Education And Training In The United StatesPsychology Education And Training In The United States
Psychology Education And Training In The United StatesMarco Peña
 
Laboratory Medicine Internship Booklet (1).pdf
Laboratory Medicine Internship Booklet (1).pdfLaboratory Medicine Internship Booklet (1).pdf
Laboratory Medicine Internship Booklet (1).pdfYokasaranya
 
Competency Validation: An Advisory Board Approach
Competency Validation: An Advisory Board ApproachCompetency Validation: An Advisory Board Approach
Competency Validation: An Advisory Board ApproachAPI Healthcare
 

Semelhante a Guidelines for principals on planning and evaluations of trainings,Guidelines for observational studies conducted on drugs, published by Turkish Medicine and Medical Device Agency (20)

Ich gcp guidlines 2021
Ich gcp guidlines 2021Ich gcp guidlines 2021
Ich gcp guidlines 2021
 
Introduction to clinical research
Introduction to clinical researchIntroduction to clinical research
Introduction to clinical research
 
Cinical trial protocol writing
Cinical trial protocol writingCinical trial protocol writing
Cinical trial protocol writing
 
Simple steps to NABH Accreditation
Simple steps to NABH AccreditationSimple steps to NABH Accreditation
Simple steps to NABH Accreditation
 
DEVELOPING THE CLINICAL TRIAL PROTOCOL | PPT
DEVELOPING THE CLINICAL TRIAL PROTOCOL | PPTDEVELOPING THE CLINICAL TRIAL PROTOCOL | PPT
DEVELOPING THE CLINICAL TRIAL PROTOCOL | PPT
 
Lab qms lesson one
Lab qms  lesson oneLab qms  lesson one
Lab qms lesson one
 
md_qp_prospectus
md_qp_prospectusmd_qp_prospectus
md_qp_prospectus
 
Clinical Trial Program
Clinical Trial ProgramClinical Trial Program
Clinical Trial Program
 
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIALICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
 
Ich gcp
Ich gcpIch gcp
Ich gcp
 
PCORI Methodology Committee Report
PCORI Methodology Committee ReportPCORI Methodology Committee Report
PCORI Methodology Committee Report
 
A researcher's guide to understanding clinical trials part 2
A researcher's guide to understanding clinical trials part 2A researcher's guide to understanding clinical trials part 2
A researcher's guide to understanding clinical trials part 2
 
mohammad CV June 2014 (2)
mohammad CV June 2014 (2)mohammad CV June 2014 (2)
mohammad CV June 2014 (2)
 
Clinical effectiveness
Clinical effectivenessClinical effectiveness
Clinical effectiveness
 
Health screener diploma national update 2019 figures and support
Health screener diploma national update 2019 figures and supportHealth screener diploma national update 2019 figures and support
Health screener diploma national update 2019 figures and support
 
GLP FINAL.pptx
GLP FINAL.pptxGLP FINAL.pptx
GLP FINAL.pptx
 
Psychology Education And Training In The United States
Psychology Education And Training In The United StatesPsychology Education And Training In The United States
Psychology Education And Training In The United States
 
Preparation of protocol
Preparation of protocolPreparation of protocol
Preparation of protocol
 
Laboratory Medicine Internship Booklet (1).pdf
Laboratory Medicine Internship Booklet (1).pdfLaboratory Medicine Internship Booklet (1).pdf
Laboratory Medicine Internship Booklet (1).pdf
 
Competency Validation: An Advisory Board Approach
Competency Validation: An Advisory Board ApproachCompetency Validation: An Advisory Board Approach
Competency Validation: An Advisory Board Approach
 

Mais de Serkan Kaçar

Guidelines regarding independent data monitoring committees, published by Tur...
Guidelines regarding independent data monitoring committees, published by Tur...Guidelines regarding independent data monitoring committees, published by Tur...
Guidelines regarding independent data monitoring committees, published by Tur...Serkan Kaçar
 
Guidelines on the manner of application to Guidelines on the manner of applic...
Guidelines on the manner of application to Guidelines on the manner of applic...Guidelines on the manner of application to Guidelines on the manner of applic...
Guidelines on the manner of application to Guidelines on the manner of applic...Serkan Kaçar
 
Guidelines on the manner of application to the ethics committee in clinical t...
Guidelines on the manner of application to the ethics committee in clinical t...Guidelines on the manner of application to the ethics committee in clinical t...
Guidelines on the manner of application to the ethics committee in clinical t...Serkan Kaçar
 
Guidelines on the collection verification and submission of reports on advers...
Guidelines on the collection verification and submission of reports on advers...Guidelines on the collection verification and submission of reports on advers...
Guidelines on the collection verification and submission of reports on advers...Serkan Kaçar
 
Guidelines on storage and distribution of investigational products, published...
Guidelines on storage and distribution of investigational products, published...Guidelines on storage and distribution of investigational products, published...
Guidelines on storage and distribution of investigational products, published...Serkan Kaçar
 
Guidelines on insuring volunteers in a clinical trial, published by Turkish M...
Guidelines on insuring volunteers in a clinical trial, published by Turkish M...Guidelines on insuring volunteers in a clinical trial, published by Turkish M...
Guidelines on insuring volunteers in a clinical trial, published by Turkish M...Serkan Kaçar
 
Guidelines on ethical approaches for clinical trials conducted with the pedia...
Guidelines on ethical approaches for clinical trials conducted with the pedia...Guidelines on ethical approaches for clinical trials conducted with the pedia...
Guidelines on ethical approaches for clinical trials conducted with the pedia...Serkan Kaçar
 
Guidelines for site organization management in clinical_trials, published by ...
Guidelines for site organization management in clinical_trials, published by ...Guidelines for site organization management in clinical_trials, published by ...
Guidelines for site organization management in clinical_trials, published by ...Serkan Kaçar
 
Guidelines for principles and rules for good clinical practices of advanced t...
Guidelines for principles and rules for good clinical practices of advanced t...Guidelines for principles and rules for good clinical practices of advanced t...
Guidelines for principles and rules for good clinical practices of advanced t...Serkan Kaçar
 
Guidelines for observational studies conducted on drugs, published by Turkish...
Guidelines for observational studies conducted on drugs, published by Turkish...Guidelines for observational studies conducted on drugs, published by Turkish...
Guidelines for observational studies conducted on drugs, published by Turkish...Serkan Kaçar
 
Guidelines for archiving in clinical trials published by Turkish Medicine and...
Guidelines for archiving in clinical trials published by Turkish Medicine and...Guidelines for archiving in clinical trials published by Turkish Medicine and...
Guidelines for archiving in clinical trials published by Turkish Medicine and...Serkan Kaçar
 
GCP Guideline published by Turkish Medicine and Medical Device Agency
GCP Guideline published by Turkish Medicine and Medical Device AgencyGCP Guideline published by Turkish Medicine and Medical Device Agency
GCP Guideline published by Turkish Medicine and Medical Device AgencySerkan Kaçar
 
The EFGCP Report For Clinical Research Projects in Turkey
The EFGCP Report For Clinical Research Projects in TurkeyThe EFGCP Report For Clinical Research Projects in Turkey
The EFGCP Report For Clinical Research Projects in TurkeySerkan Kaçar
 
Regulation on clinical trials turkey
Regulation on clinical trials turkeyRegulation on clinical trials turkey
Regulation on clinical trials turkeySerkan Kaçar
 
Clinical Trials In Turkey
Clinical Trials In TurkeyClinical Trials In Turkey
Clinical Trials In TurkeySerkan Kaçar
 

Mais de Serkan Kaçar (18)

Statement
StatementStatement
Statement
 
Textile Dictionary
Textile DictionaryTextile Dictionary
Textile Dictionary
 
Guidelines regarding independent data monitoring committees, published by Tur...
Guidelines regarding independent data monitoring committees, published by Tur...Guidelines regarding independent data monitoring committees, published by Tur...
Guidelines regarding independent data monitoring committees, published by Tur...
 
Guidelines on the manner of application to Guidelines on the manner of applic...
Guidelines on the manner of application to Guidelines on the manner of applic...Guidelines on the manner of application to Guidelines on the manner of applic...
Guidelines on the manner of application to Guidelines on the manner of applic...
 
Guidelines on the manner of application to the ethics committee in clinical t...
Guidelines on the manner of application to the ethics committee in clinical t...Guidelines on the manner of application to the ethics committee in clinical t...
Guidelines on the manner of application to the ethics committee in clinical t...
 
Guidelines on the collection verification and submission of reports on advers...
Guidelines on the collection verification and submission of reports on advers...Guidelines on the collection verification and submission of reports on advers...
Guidelines on the collection verification and submission of reports on advers...
 
Guidelines on storage and distribution of investigational products, published...
Guidelines on storage and distribution of investigational products, published...Guidelines on storage and distribution of investigational products, published...
Guidelines on storage and distribution of investigational products, published...
 
Guidelines on insuring volunteers in a clinical trial, published by Turkish M...
Guidelines on insuring volunteers in a clinical trial, published by Turkish M...Guidelines on insuring volunteers in a clinical trial, published by Turkish M...
Guidelines on insuring volunteers in a clinical trial, published by Turkish M...
 
Guidelines on ethical approaches for clinical trials conducted with the pedia...
Guidelines on ethical approaches for clinical trials conducted with the pedia...Guidelines on ethical approaches for clinical trials conducted with the pedia...
Guidelines on ethical approaches for clinical trials conducted with the pedia...
 
Guidelines for site organization management in clinical_trials, published by ...
Guidelines for site organization management in clinical_trials, published by ...Guidelines for site organization management in clinical_trials, published by ...
Guidelines for site organization management in clinical_trials, published by ...
 
Guidelines for principles and rules for good clinical practices of advanced t...
Guidelines for principles and rules for good clinical practices of advanced t...Guidelines for principles and rules for good clinical practices of advanced t...
Guidelines for principles and rules for good clinical practices of advanced t...
 
Guidelines for observational studies conducted on drugs, published by Turkish...
Guidelines for observational studies conducted on drugs, published by Turkish...Guidelines for observational studies conducted on drugs, published by Turkish...
Guidelines for observational studies conducted on drugs, published by Turkish...
 
Guidelines for archiving in clinical trials published by Turkish Medicine and...
Guidelines for archiving in clinical trials published by Turkish Medicine and...Guidelines for archiving in clinical trials published by Turkish Medicine and...
Guidelines for archiving in clinical trials published by Turkish Medicine and...
 
GCP Guideline published by Turkish Medicine and Medical Device Agency
GCP Guideline published by Turkish Medicine and Medical Device AgencyGCP Guideline published by Turkish Medicine and Medical Device Agency
GCP Guideline published by Turkish Medicine and Medical Device Agency
 
The EFGCP Report For Clinical Research Projects in Turkey
The EFGCP Report For Clinical Research Projects in TurkeyThe EFGCP Report For Clinical Research Projects in Turkey
The EFGCP Report For Clinical Research Projects in Turkey
 
Regulation on clinical trials turkey
Regulation on clinical trials turkeyRegulation on clinical trials turkey
Regulation on clinical trials turkey
 
Yönetmelik 6579492
Yönetmelik 6579492Yönetmelik 6579492
Yönetmelik 6579492
 
Clinical Trials In Turkey
Clinical Trials In TurkeyClinical Trials In Turkey
Clinical Trials In Turkey
 

Último

Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 

Último (20)

Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 

Guidelines for principals on planning and evaluations of trainings,Guidelines for observational studies conducted on drugs, published by Turkish Medicine and Medical Device Agency

  • 1. GUIDELINES FOR PRINCIPALS ON PLANNING AND EVALUATIONS OF TRAININGS 17.04.2013 1. OBJECTIVE This document aims to provide guidance on the content and the format of the submissions that will be done to Turkish Medicine and Medical Device Agency regarding the planned training programs about good clinical practices and clinical research. 2. BASIC PRINCIPLES 2.1 The participants’ number should be minimum 40 and maximum 80. 2.2 There should be at least 2 workshops according to training composition. 2.3 There should be at least one role-play video if it is appropriate for planned training composition. 2.4 There should be a laptop with the internet connection, projector, DVD or VCD player, audio system (including lapel microphone) at the training place. 2.5 There should be “question and answer application” supported by a computer system. 2.6 The physical place for training should be a big lounge with the table sitting arrangement and preferred to be changed as 2 small lounges if needed. 2.7 The Training Coordinator who will be qualified to answer all kind of management and educational questions should be assigned during the training. 3. APPLICATIONS 3.1 A Quality Assurance Responsible should be present during the training for assessing presentation of the trainer, trainers’ ability to answers questions raised and trainers’ interest in participants. 3.2 The expectation of participants should be questioned at the beginning of the training and compared with the anticipated objectives. 3.3 The participants should be pre-tested to evaluate their knowledge level at the beginning of the training 3.4 Mandatory training attendances should be planned as ¾ attendance per course 3.5 Preferably the signature of participants should be collected for each presentation, if not possible for each session. 3.6 Each participant should be provided with a name tag, agenda of training, course notes and also note book and a pen. 3.7 If the training is planned for more than one day, the training from previous day should be summarized. 3.8 Before starting the advanced training session, participants should be reminded about the content of the basic training. 3.9 Training presentations and workshops should not exceed respectively 40 minutes, and 3 hours. 4. EVALUATIONS 4.1 Training evaluation should be completed under2 titles; “the participants’ success assessment” and “evaluation of the training program”
  • 2. GUIDELINES FOR PRINCIPALS ON PLANNING AND EVALUATIONS OF TRAININGS 17.04.2013 The participants’ success assessment; the participants’ success should be evaluated with an exam at the end of the training. Participants who have passed the exam and whose continuation is appropriate should receive a “Certificate of Achievement” .Participants who have failed the exam should be given a “Registration Certificate”. 4.1.2 Evaluation of the training program; In order to evaluate effectiveness of the training program, feedbacks of the participants should be collected. 4.2 “Certificate of Achievement” and/or “Registration Certificate” should be signed by Training Coordinator. 4.1.1 5. TRAINERS 5.1 Trainers should experts on their subjects. 5.2 Trainers who are not academics should receive the “Train the Trainer” training. 6. EXAMPLES FOR THE TRAINING PROGRAM Below listed training programs are suggested as example. The content of the course can be amended according to course title. 6.1 Ethical approach and considerations in clinical trials 6.1.1 Duration of the Training: It should be minimum 2, maximum 4 days 6.1.2 Target Audience: The training should be intended for Ethics Committee members and investigators. 6.1.3 Objective: The objective of the training is to understand basic ethical approaches and principles in clinical research. 6.1.4 It may planned as 2 modules; The scope of Module 1: The scope of the training may include following topics;  Philosophy and historical progress of ethics in clinical research  Ethical aspects of clinical research  National legislations in clinical research  Mission, authority and responsibilities of Ethics Committees  Qualification of Ethics Committees  Composition, functions and operations of Ethics Committees  Items that make clinical research ethical  Wrong attitudes in clinical research  Conflict of interest in clinical research  Statistical evaluation in clinical research and reliability of data  Ethical approval process  Ethics Committee/ investigator relationship The scope of Module 2: The scope of the training may include following topics;  Quality control and assurance in clinical research  Methodology in clinical trials  Statistical approaches in clinical trials  Clinical trials in Geriatric population  Source of mistakes in different types of clinical research
  • 3. GUIDELINES FOR PRINCIPALS ON PLANNING AND EVALUATIONS OF TRAININGS 17.04.2013  Ethical aspects of observational studies  Problems in implementation  Use of placebo in psychiatric studies  Ethical aspects of genetic researches  Ethical approaches in clinical trials involving female subjects  Clinical trials involving healthy subjects  Pharmacovigilence and adverse events  Clinical trials in pediatric population 6.2 Training program about the standardization requirements for structuring of Ethics Committees 6.2.1 Duration of the Training: It should be minimum 2, maximum 4 days 6.2.2 Target Audience: The training should be intended for Ethics Committee members. 6.2.3 Objective: The objective of the training is to understand basic ethical approaches and principles in clinical research. 6.2.4 Scope; The scope of the training may include following topics;  European Union Directives, national legislations  Legal regulations in clinical trials  What is Good Clinical Practice(GCP)?  Composition, functions and operations of Ethics Committees  Qualification of Ethics Committees  Mission, authority and responsibilities of Ethics Committees  What is ethics? Bioethics and ethics in clinical research  Historical progress of ethical values in clinical research  Patient rights  Importance of Declaration of Helsinki and its parts to follow  Importance of Informed Consent Form (ICF) and evaluation of ICD during submissions(workshop)  The need for drug development, milestones in drug development and different phases of clinical trials  Statistical evaluation in clinical research and reliability of data  Quality Management-basic principles  Definition of “Standard Operating Procedure”, its reason for use and content  Preparation of “Standard Operating Procedure”(workshop)  Quality control and assurance in clinical research  Budgeting in clinical trials: payments to subjects and investigators  Evaluation of a submission folder (workshop)  Ethic approval process  Safety notifications in clinical research  Ethics Committee/ investigator relationship  Ethics Committee/ sponsor relationship  Conflict of interest in clinical research 6.3 Clinical Research/Basic Training Program
  • 4. GUIDELINES FOR PRINCIPALS ON PLANNING AND EVALUATIONS OF TRAININGS 6.3.1 6.3.2 6.3.3 6.3.4 17.04.2013 Duration of the Training: It should be minimum 2, maximum 4 days Target Audience: The training should be intended for investigators and sponsors. Objective: The objective of the training is to understand basic principles of clinical research. :It may planned as 2 modules; The scope of Module 1: The scope of the training may include following topics;  New Drug development process  Clinical research terminology  The duties and responsibilities of the parties involved in Clinical Trials  Observational studies  Non-Drug clinical trials terminology  Information of subjects and informed consent form  Legal regulations  Adverse event reporting  The practices of local authority in accordance with the relevant legislation The scope of Module 2: The scope of the training may include following topics;  Clinical Trial Protocol  Investigators’ Brochure  Basic Statistical Terms  Pharmacokinetic Terms  Pharmacogenetic and Pharmacogenomic Terms  Quality Control in Clinical Trials  Protection of patients and Helsinki Declarations  Designing of Clinical Trials  Methodology in Clinical Trials (blinding, randomization etc.)  Placebo Controls in Clinical Trials  Project Management in Clinical Trials  Special parameters in clinical trials(Life Quality etc. )  Data Management(collection of the data, data entry, validation of the data etc)  Data reliability/safety 6.4 Monitoring in Clinical Trials 6.4.1 Duration of the Training: It should be minimum 2, maximum 3 days 6.4.2 Target Audience: The training should be intended for sponsors and monitors. 6.4.3 Objective: The objective of the training is to understand basic principles of monitoring in clinical trials. 6.4.4 Scope; The scope of the training may include following topics;  Monitoring policy  Legal regulations in clinical trials  Introduction to Good Clinical Practice(GCP)  Introduction to Good Laboratory Practice(GLP)  Quality assurance and standard operating procedures
  • 5. GUIDELINES FOR PRINCIPALS ON PLANNING AND EVALUATIONS OF TRAININGS 17.04.2013        Terminology in clinical trials Essential documents in study files Inappropriate behavior in clinical trials Selection and qualifications of Monitors Monitor’s responsibilities Reporting Data Management(collection of the data, data entry, validation of the data etc)  Data reliability/safety  Investigational product accountability and destruction 6.5 Clinical Research Nursing Training Program 6.5.1 Duration of the Training: It should be minimum 2, maximum 3 days 6.5.2 Target Audience: The training should be intended for clinical research nurses 6.5.3 Objective: The objective of the training is to understand basic principles of clinical trials. 6.5.4 Scope; The scope of the training may include following topics;  Clinical research terminology  Legal regulations in clinical trials  Definition of clinical research and steps of designing clinical trials  Ethics Committees in clinical trials  Management of trial site  Clinical research nursing  Responsibilities in clinical researches  Randomization procedures and blinding in clinical trials  Source documents in clinical trials  Submission periods in clinical trials  Investigational product procedures  Study close-out  Adverse event reporting 6.6 Advanced Clinical Research Training Program 6.6.1 Duration of the Training: It should be minimum 2, maximum 4 days 6.6.2 Target Audience: The training should be intended for investigators and sponsors. 6.6.3 Objective: The objective of the training is to understand more specific topics of clinical research. 6.6.4 Scope; The scope of the training may include following topics;  Data management in Clinical Trials  Risk Management in Clinical Trials  Finding volunteers and retention in Clinical Trials  Types of research on specific topics such as oncology trials, psychiatry trials  Evaluation of statistical data  Translational researches
  • 6. GUIDELINES FOR PRINCIPALS ON PLANNING AND EVALUATIONS OF TRAININGS 17.04.2013  Pharmacogenetic and Pharmacogenomic  Causality relationships in safety notifications  The scales used in research and evaluations Protocol Writing 6.7 Clinical Research Pharmacist Training Program 6.7.1 Duration of the Training: It should be minimum 2, maximum 3 days 6.7.2 Target Audience: The training should be intended for clinical research pharmacists 6.7.3 Objective: The objective of the training is to understand basic principles of clinical trials. 6.7.4 Scope; The scope of the training may include following topics;  Clinical research terminology  Legal regulations in clinical trials  Definition of clinical research and steps of designing clinical trials  Management of trial site  Task and responsibilities of clinical research pharmacists  Randomization procedures and blinding in clinical trials  Source documents in clinical trials  Investigational product procedures and accountability  Study close-out  Adverse event reporting 7. SUBMISSION AND APPROVAL 7.1 Submissions to Turkish Medicine and Medical Device Agency should be completed latest one month before with the form and cover letter published in Institution’s website. The approval for organization of the training is granted upon evaluation, to those who were found qualified. 7.2 The training should be organized in collaboration with an institution, an university or a research and training hospital. 8. ANNULLED REGULATIONS Guidance for Principals on Planning and Evaluations of Trainings which entered into force in accordance with the presidency approval dated 28.05.2012 and no 48797 was abolished. 9. ENFORCEMENT This guideline will enter into force on the date of approval.